These data suggest that the increased mRNA expression of FTO could be responsible for the reduction of m(6)A in T2DM, which may further increase the risk of complications of T2DM. Low m(6)A should be investigated further as a novel potential biomarker of T2DM.
No takes yet. Share an insight, caveat, or question.
Shen et al. (2014) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: